Suppr超能文献

相似文献

1
Sinus Surgery Is Associated with a Decrease in Aspirin-Induced Reaction Severity in Patients with Aspirin Exacerbated Respiratory Disease.
J Allergy Clin Immunol Pract. 2019 May-Jun;7(5):1580-1588. doi: 10.1016/j.jaip.2018.12.014. Epub 2018 Dec 21.
2
Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease.
Ann Allergy Asthma Immunol. 2016 Apr;116(4):321-328.e1. doi: 10.1016/j.anai.2015.12.026. Epub 2016 Jan 25.
3
Endoscopic sinus surgery improves aspirin treatment response in aspirin-exacerbated respiratory disease patients.
Int Forum Allergy Rhinol. 2019 Dec;9(12):1401-1408. doi: 10.1002/alr.22418. Epub 2019 Sep 30.
4
Prostaglandin D₂: a dominant mediator of aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol. 2015 Jan;135(1):245-52. doi: 10.1016/j.jaci.2014.07.031. Epub 2014 Sep 11.
5
Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol. 2021 Aug;148(2):574-584. doi: 10.1016/j.jaci.2021.05.043. Epub 2021 Jun 16.
7
Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol. 2017 Jul;140(1):101-108.e3. doi: 10.1016/j.jaci.2016.11.023. Epub 2017 Mar 6.
8
Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol. 2016 May;137(5):1566-1576.e5. doi: 10.1016/j.jaci.2015.10.020. Epub 2015 Dec 12.
9
Trial of thromboxane receptor inhibition with ifetroban: TP receptors regulate eicosanoid homeostasis in aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol. 2023 Sep;152(3):700-710.e3. doi: 10.1016/j.jaci.2023.03.030. Epub 2023 Apr 15.
10
Dietary Fatty Acid Modification for the Treatment of Aspirin-Exacerbated Respiratory Disease: A Prospective Pilot Trial.
J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):825-831. doi: 10.1016/j.jaip.2017.10.011. Epub 2017 Nov 10.

引用本文的文献

1
Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: A WAO Statement.
World Allergy Organ J. 2025 Aug 12;18(8):101086. doi: 10.1016/j.waojou.2025.101086. eCollection 2025 Aug.
2
Chronic rhinosinusitis with nasal polyps: Key considerations in the multidisciplinary team approach.
Clin Transl Allergy. 2025 Jan;15(1):e70010. doi: 10.1002/clt2.70010.
3
Updates on the Natural History and Clinical Characteristics of NSAID-ERD.
J Allergy Clin Immunol Pract. 2024 Nov;12(11):2889-2896. doi: 10.1016/j.jaip.2024.07.013. Epub 2024 Jul 20.
4
[Expert consensus on the diagnosis and treatment of respiratory diseases exacerbated by nonsteroidal anti-inflammatory drugs (2024, Chengdu)].
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2024 Jun;38(6):453-462. doi: 10.13201/j.issn.2096-7993.2024.06.001.
5
Pre-asthma: a useful concept? A EUFOREA paper. Part 2-late onset eosinophilic asthma.
Front Allergy. 2024 May 15;5:1404735. doi: 10.3389/falgy.2024.1404735. eCollection 2024.
6
Aspirin-exacerbated respiratory disease is associated with variants in filaggrin, epithelial integrity, and cellular interactions.
J Allergy Clin Immunol Glob. 2024 Jan 9;3(2):100205. doi: 10.1016/j.jacig.2024.100205. eCollection 2024 May.
7
Should Biologics Be Used Before Aspirin Desensitization in Aspirin-Exacerbated Respiratory Disease?
J Allergy Clin Immunol Pract. 2024 Jan;12(1):79-84. doi: 10.1016/j.jaip.2023.09.019. Epub 2023 Sep 29.
9
Lung Function and Asthma Clinical Control in N-ERD Patients, Three-Year Follow-Up in the Context of Real-World Evidence.
J Asthma Allergy. 2023 Sep 6;16:937-950. doi: 10.2147/JAA.S418802. eCollection 2023.
10
The role of oxylipins in NSAID-exacerbated respiratory disease (N-ERD).
Adv Pharmacol. 2023;97:423-444. doi: 10.1016/bs.apha.2022.12.002. Epub 2023 Jan 10.

本文引用的文献

1
Aspirin-Exacerbated Respiratory Disease.
N Engl J Med. 2018 Sep 13;379(11):1060-1070. doi: 10.1056/NEJMra1712125.
2
Comparable safety of 2 aspirin desensitization protocols for aspirin exacerbated respiratory disease.
J Allergy Clin Immunol Pract. 2019 Apr;7(4):1319-1321. doi: 10.1016/j.jaip.2018.08.004. Epub 2018 Aug 23.
3
Urinary Leukotriene E4 to Determine Aspirin Intolerance in Asthma: A Systematic Review and Meta-Analysis.
J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):990-997.e1. doi: 10.1016/j.jaip.2016.11.004. Epub 2017 Feb 12.
4
Plasma 15-Hydroxyeicosatetraenoic Acid Predicts Treatment Outcomes in Aspirin-Exacerbated Respiratory Disease.
J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):998-1007.e2. doi: 10.1016/j.jaip.2016.11.021. Epub 2017 Jan 31.
6
Diagnostic Utility of Urinary LTE4 in Asthma, Allergic Rhinitis, Chronic Rhinosinusitis, Nasal Polyps, and Aspirin Sensitivity.
J Allergy Clin Immunol Pract. 2016 Jul-Aug;4(4):665-70. doi: 10.1016/j.jaip.2016.03.004. Epub 2016 Apr 12.
7
Aspirin-Exacerbated Respiratory Disease--New Prime Suspects.
N Engl J Med. 2016 Feb 4;374(5):484-8. doi: 10.1056/NEJMcibr1514013.
8
Utility of low-dose oral aspirin challenges for diagnosis of aspirin-exacerbated respiratory disease.
Ann Allergy Asthma Immunol. 2016 Apr;116(4):321-328.e1. doi: 10.1016/j.anai.2015.12.026. Epub 2016 Jan 25.
9
Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease.
J Allergy Clin Immunol. 2016 May;137(5):1566-1576.e5. doi: 10.1016/j.jaci.2015.10.020. Epub 2015 Dec 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验